Pathology of Hepatic Iron Overload

 

 Buy Article Permissions and Reprints

ABSTRACT

The role of liver biopsy in all chronic liver diseases continues to evolve with the emergence of new laboratory and imaging tests. However, the value of histologic examination for fibrosis, parenchymal architectural remodeling, and possible concurrent disease remains relatively unchallenged, including in patients with suspected iron overload. In addition, only histologic evaluation allows detailed analysis of cellular and acinar localization of iron. Routine use of an iron stain for all liver biopsy analysis enables detection of iron when not otherwise suspected.

The broad classifications of iron overload include parenchymal (“primary”) or reticuloendothelial (“secondary”), and mixed. These classifications, however, serve only as guidelines to differential diagnoses, as will be noted in the following review of pathology of iron overload. Ultimately, the role of the pathologist is to document cellular and acinar localization of iron and to provide a semiquantitative assessment of amount to alert the clinician to the possibility of a significant condition.

In this article, histopathologic findings in conditions of iron overload and in several forms of liver disease are discussed.

REFERENCES

• 1 Feder J N, Gnirke A, Thomas W et al.. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.  Nat Genet. 1996;  13 399-408
  CrossrefPubMedGoogle Scholar
• 2 Pietrangelo A. Non-invasive assessment of hepatic iron overload: are we finally there?.  J Hepatol. 2005;  42 153-154
  PubMedGoogle Scholar
• 3 Bacon B R, Powell L W, Adams P C, Kresina T F, Hoofnagle J H. Molecular medicine and hemochromatosis: at the crossroads.  Gastroenterology. 1999;  116 193-207
  PubMedGoogle Scholar
• 4 Bacon B R. Hereditary hemochromatosis: diagnosis and management.  Gastroenterology. 2001;  120 718-725
  PubMedGoogle Scholar
• 5 Bacon B R, Olynyk J K, Brunt E M, Britton R S, Wolff R K. HFE genotype in patients with hemochromatosis and other liver diseases.  Ann Intern Med. 1999;  130 953-962
  CrossrefPubMedGoogle Scholar
• 6 Bridle K R, Crawford DHG, Fletcher L M, Smith J L, Powell L W, Ramm G A. Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis.  J Hepatol. 2003;  38 426-433
  CrossrefPubMedGoogle Scholar
• 7 Hubscher S G. Iron overload, inflammation and fibrosis in genetic haemochromatosis [editorial].  J Hepatol. 2003;  38 521-525
  CrossrefPubMedGoogle Scholar
• 8 Ramm G A, Crawford DHG, Powell L W, Walker N I, Fletcher L M, Halliday J W. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy.  J Hepatol. 1997;  26 584-592
  CrossrefPubMedGoogle Scholar
• 9 Ludwig J, Batts K P, Moyer P M, Baldus W P, Fairbanks V F. Liver biopsy diagnosis of homozygous hemochromatosis: a diagnostic algorithm.  Mayo Clin Proc. 1993;  68 263-267
  PubMedGoogle Scholar
• 10 Brunt E M, Olynyk J K, Britton R S, Janney C G, Di Bisceglie A M, Bacon B R. Histological evaluation of iron in liver biopsies: relationship to HFE mutations.  Am J Gastroenterol. 2000;  95 1788-1793
  PubMedGoogle Scholar
• 11 Turlin B, Deugnier Y. Evaluation and interpretation of iron in the liver.  Semin Diagn Pathol. 1998;  15 237-245
  PubMedGoogle Scholar
• 12 Bartolo C, McAndrew P E, Sosolik R C et al.. Differential diagnosis of hereditary hemochromatosis from other liver disorders by genetic analysis.  Arch Pathol Lab Med. 1998;  122 633-637
  PubMedGoogle Scholar
• 13 Tavill A S. Diagnosis and management of hemochromatosis.  Hepatology. 2001;  33 1321-1328
  CrossrefPubMedGoogle Scholar
• 14 Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis.  Gastroenterology. 1996;  110 1107-1119
  CrossrefPubMedGoogle Scholar
• 15 Olynyk J K, St. Pierre T G, Britton R S, Brunt E M, Bacon B R. Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging.  Am J Gastroenterol. 2005;  100 837-841
  CrossrefPubMedGoogle Scholar
• 16 Fargion S, Mattioli M, Fracanzani A L, Fiorelli G. Iron and liver diseases.  Can J Gastroenterol. 2000;  14 89D-92D
  PubMedGoogle Scholar
• 17 Pietrangelo A. Hemochromatosis gene modifies courses of hepatitis C viral infection.  Gastroenterology. 2003;  124 1509-1523
  CrossrefPubMedGoogle Scholar
• 18 Fletcher L M, Dixon J L, Purdie D M, Powell L W, Crawford DHG. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis.  Gastroenterology. 2002;  122 281-289
  CrossrefPubMedGoogle Scholar
• 19 Tavill A S, Qadri A M. Alcohol and iron.  Semin Liver Dis. 2004;  24 317-325
  Article in Thieme ConnectPubMedGoogle Scholar
• 20 Chitturi S, George J. Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.  Curr Gastroenterol Rep. 2003;  5 18-25
  PubMedGoogle Scholar
• 21 Bugianesi E, Manzini P, D'Antico S et al.. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.  Hepatology. 2004;  39 179-187
  CrossrefPubMedGoogle Scholar
• 22 Eriksson S, Lindmark B, Olsson S. Lack of association between hemochromatosis and alpha-antitrypsin deficiency.  Acta Med Scand. 1986;  219 291-294
  PubMedGoogle Scholar
• 23 Fargion S, Bissoli F, Fracanzani A L et al.. No association between genetic hemochromatosis and α1-antitrypsin deficiency.  Hepatology. 1996;  24 1161-1164
  PubMedGoogle Scholar
• 24 Elzouki A-NY, Hultcrantz R, Stal P, Befrits R, Eriksson S. Increased PiZ gene frequency for α1-antitrypsin in patients with genetic haemochromatosis.  Gut. 1995;  36 922-926
  PubMedGoogle Scholar
• 25 Rabinovitz M, Gavaler J S, Kelly R H, Van Thiel D H. Association between heterozygous α1-antitrypsin deficiency and genetic hemochromatosis.  Hepatology. 1992;  16 145-148
  PubMedGoogle Scholar
• 26 Scheuer P J, Williams R, Muir A R. Hepatic pathology in relatives of patients with haemochromatosis.  J Pathol Bacteriol. 1962;  84 53-64
  CrossrefPubMedGoogle Scholar
• 27 Deugnier Y M, Loreal O, Turlin B et al.. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations.  Gastroenterology. 1992;  102 2050-2059
  PubMedGoogle Scholar
• 28 Diwakaran H H, Befeler A S, Britton R S, Brunt E M, Bacon B R. Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection.  J Hepatol. 2002;  36 687-691
  CrossrefPubMedGoogle Scholar
• 29 Olynyk J K, Cullen D J, Aquilia S, Rossi E, Summerville L, Powell L W. A population-based study of the clinical expression of the hemochromatosis gene.  N Engl J Med. 1999;  341 718-724
  CrossrefPubMedGoogle Scholar
• 30 Gochee P A, Powell L W, Cullen D J, Du Sart D, Rossi E, Olynyk J K. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.  Gastroenterology. 2002;  122 646-651
  CrossrefPubMedGoogle Scholar
• 31 Schoniger-Hekele M, Muller C, Polli C, Wrba F, Penner E, Ferenci P. Liver pathology in compound heterozygous patients for hemochromatosis mutations.  Liver. 2002;  22 295-301
  PubMedGoogle Scholar
• 32 Pietrangelo A. Non-HFE hemochromatosis.  Hepatology. 2004;  39 21-29
  CrossrefPubMedGoogle Scholar
• 33 Pietrangelo A, Caleffi A, Henrion J et al.. Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes.  Gastroenterology. 2005;  128 470-479
  CrossrefPubMedGoogle Scholar
• 34 Fleming R E, Bacon B R. Orchestration of iron homeostasis.  N Engl J Med. 2005;  352 1741-1744
  CrossrefPubMedGoogle Scholar
• 35 Eason R J, Adams P C, Aston C E, Searle J. Familial iron overload with possible autosomal dominant inheritance.  Aust N Z J Med. 1990;  20 226-230
  PubMedGoogle Scholar
• 36 Morita H, Ikeda S, Yamamoto K et al.. Hereditary ceruloplasminemia deficiency with hemochromatosis: a clinicopathological study of a Japanese family.  Ann Neurol. 1995;  37 646-656
  CrossrefPubMedGoogle Scholar
• 37 Fairbanks V F, Beutler E. Congenital atransferrinemia and idiopathic pulmonary hemosiderosis. In: Williams WJ, Beutler E, Erslev AJ Hematology. New York, NY; McGraw Hill 1983: 489-492
  Google Scholar
• 38 Kershisnik M M, Knisely A S, Sun C-CJ, Andrews J M, Wittwer C T. Cytomegalovirus infection, fetal liver disease, and neonatal hemochromatosis.  Hum Pathol. 1992;  23 1075-1080
  CrossrefPubMedGoogle Scholar
• 39 Adams P C, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings.  Hepatology. 1996;  23 724-727
  CrossrefPubMedGoogle Scholar
• 40 Jakobovits A W, Morgan M Y. Hepatic siderosis in alcoholics.  Dig Dis Sci. 1979;  24 305-310
  CrossrefPubMedGoogle Scholar
• 41 Bassett M L, Halliday J W, Powell L W. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis.  Hepatology. 1986;  6 24-29
  PubMedGoogle Scholar
• 42 Brunt E M. Alcoholic and nonalcoholic steatohepatitis.  Clin Liver Dis. 2002;  6 399-420
  CrossrefPubMedGoogle Scholar
• 43 Brunt E M. Nonalcoholic steatohepatitis: definition and pathology.  Semin Liver Dis. 2001;  21 3-16
  Article in Thieme ConnectPubMedGoogle Scholar
• 44 Brunt E M, Janney C G, Di Bisceglie A M, Neuschwander-Tetri B A, Bacon B R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.  Am J Gastroenterol. 1999;  94 2467-2474
  CrossrefPubMedGoogle Scholar
• 45 Brunt E M, Neuschwander-Tetri B A, Oliver D, Wehmeier K R, Bacon B R. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens.  Hum Pathol. 2004;  35 1070-1085
  CrossrefPubMedGoogle Scholar
• 46 Ferrannini E. Insulin resistance, iron, and the liver.  Lancet. 2000;  355 2181-2182
  CrossrefPubMedGoogle Scholar
• 47 George D K, Goldwurm S, MacDonald G A et al.. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.  Gastroenterology. 1998;  114 311-318
  CrossrefPubMedGoogle Scholar
• 48 Bonkovsky H L, Zivny J, Tortorelli K, Liu Q, Lambrecht R W. Non-alcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload? Reply.  J Hepatol. 2000;  33 1025-1026
  CrossrefPubMedGoogle Scholar
• 49 Facchini F S, Hua N W, Stoohs R A. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease.  Gastroenterology. 2002;  122 931-939
  CrossrefPubMedGoogle Scholar
• 50 Angulo P, Keach J C, Batts K P, Lindor K D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.  Hepatology. 1999;  30 1356-1362
  CrossrefPubMedGoogle Scholar
• 51 Chitturi S, Weltman M, Farrell G C et al.. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.  Hepatology. 2002;  36 142-149
  CrossrefPubMedGoogle Scholar
• 52 Bhattacharya R, Kowdley K V. Iron and HFE mutations in nonalcoholic steatohepatitis: innocent bystanders or accessories to the crime?.  Gastroenterology. 2003;  125 615-616
  CrossrefPubMedGoogle Scholar
• 53 Yamauchi N, Itoh Y, Tanaka Y et al.. Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis.  J Gastroenterol. 2004;  39 654-660
  PubMedGoogle Scholar
• 54 Mendler M H, Turlin B, Moirand R et al.. Insulin resistance-associated hepatic iron overload.  Gastroenterology. 1999;  117 1155-1163
  CrossrefPubMedGoogle Scholar
• 55 Turlin B, Mendler M-H, Moirand R, Guyader D, Guillygomarc'h A, Deugnier Y. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients.  Am J Clin Path. 2001;  116 263-270
  PubMedGoogle Scholar
• 56 Bardadin K A, Scheuer P J. Endothelial cell changes in acute hepatitis: a light and electron microscopic study.  J Pathol. 1984;  144 213-220
  PubMedGoogle Scholar
• 57 Ishak K G. Light microscopic morphology of viral hepatitis.  Am J Clin Pathol. 1976;  65(5 Suppl) 787-827
  PubMedGoogle Scholar
• 58 Hengeveld P, Zuyderhoudt F M, Jobsis A C, van Gool J. Some aspects of iron metabolism during acute viral hepatitis.  Hepatogastroenterology. 1982;  29 138-141
  PubMedGoogle Scholar
• 59 Kaji K, Nakanuma Y, Sasaki M, Unoura M, Kobayashi K-I, Nonomura A. Hemosiderin deposition in portal endothelial cells: a novel hepatic hemosiderosis frequent in chronic viral hepatitis B and C.  Hum Pathol. 1995;  26 1080-1085
  CrossrefPubMedGoogle Scholar
• 60 Barton A L, Banner B F, Cable E E, Bonkovsky H. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.  Am J Clin Pathol. 1995;  103 419-424
  PubMedGoogle Scholar
• 61 Pianko S, McHutchison J G, Gordon S C et al.. Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.  J Interferon Cytokine Res. 2002;  22 483-489
  CrossrefPubMedGoogle Scholar
• 62 Bonkovsky H, Banner B F, Rothman A L. Iron and chronic viral hepatitis.  Hepatology. 1997;  25 759-768
  CrossrefPubMedGoogle Scholar
• 63 Lefkowitch J H, Yee H T, Sweeting J, Green PHR, Magun A M. Iron-rich foci in chronic viral hepatitis.  Hum Pathol. 1998;  29 116-118
  CrossrefPubMedGoogle Scholar
• 64 Fiel M I, Schiano T D, Guido M et al.. Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin.  Am J Clin Path. 2000;  113 35-39
  PubMedGoogle Scholar
• 65 Scheuer P J, Lefkowitch J H. Disturbances of copper and iron metabolism. In: Scheuer PJ, Lefkowitch JH Liver Biopsy Interpretation. London, UK; WB Saunders 2000: 275-283
  Google Scholar
• 66 Brunt E M, Tavill A S, Bacon B R. A 49-year-old man with a1-antitrypsin deficiency and abnormal iron study results.  Semin Liver Dis. 1996;  16 97-101
  PubMedGoogle Scholar
• 67 Graziadei I W, Joseph J J, Wiesner R H, Therneau T M, Batts K P, Porayko M K. Increased risk of chronic liver failure in adults with heterozygous a1-antitrypsin deficiency.  Hepatology. 1998;  28 1058-1063
  CrossrefPubMedGoogle Scholar
• 68 Ludwig J, Hashimoto E, Porayko M K, Moyer T P, Baldus W P. Hemosiderosis in cirrhosis: a study of 447 native livers.  Gastroenterology. 1997;  112 882-888
  CrossrefPubMedGoogle Scholar
• 69 Deugnier Y, Turlin B, Le Quilleuc D et al.. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis.  Am J Surg Pathol. 1997;  21 669-675
  CrossrefPubMedGoogle Scholar
• 70 Deugnier Y M, Guyader D, Crantock L et al.. Primary liver cancer in genetic hemochromatosis: a clinical, pathological and pathogenetic study of 54 cases.  Gastroenterology. 1993;  104 228-234
  PubMedGoogle Scholar
• 71 Deugnier Y M, Charalambous P, Le Quilleuc D et al.. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients.  Hepatology. 1993;  18 1363-1369
  CrossrefPubMedGoogle Scholar
• 72 Blumberg R S, Chopra S, Ibrahim R et al.. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis.  Gastroenterology. 1988;  95 1399-1402
  PubMedGoogle Scholar
• 73 Bottomley S S. Secondary iron overload disorders.  Semin Hematol. 1998;  35 77-86
  PubMedGoogle Scholar
• 74 Gordeuk V, Mukabi J, Hasstedt J et al.. Iron overload in Africa: interaction between a gene and dietary iron content.  N Engl J Med. 1992;  326 95-100
  CrossrefPubMedGoogle Scholar
• 75 Mandishona E, MacPhail A P, Gordeuk V R et al.. Dietary iron overload as a risk factor for hepatocellular carcinoma in black Africans.  Hepatology. 1998;  27 1563-1566
  CrossrefPubMedGoogle Scholar
• 76 Andrews N C. Disorders of iron metabolism.  N Engl J Med. 1999;  341 1986-1995
  CrossrefPubMedGoogle Scholar
• 77 Wurapa R K, Gordeuk V R, Brittenham G M, Khiyami A, Schechter G P, Edwards C Q. Primary iron overload in African Americans.  Am J Med. 1996;  101 9-18
  CrossrefPubMedGoogle Scholar
• 78 Barton J C, Edwards C Q, Bertoli L F, Shroyer T W, Hudson S L. Iron overload in African Americans.  Am J Med. 1995;  99 616-623
  CrossrefPubMedGoogle Scholar
• 79 Brown K E, Khan C M, Zimmerman B, Brunt E M. Hepatic iron overload in blacks and whites: a comparative autopsy study.  Am J Gastroenterol. 2003;  98 1594-1598
  CrossrefPubMedGoogle Scholar
• 80 Sindram J W, Marx JJM. Localization of iron in the hepatic acini and the bile duct epithelium as a tool for estimation of liver iron overload.  Ann NY Acad Sci. 1988;  526 361-362
  PubMedGoogle Scholar
• 81 Rowe J W, Wands J R, Mezey E et al.. Familial hemochromatosis: characteristics of the precirrhotic stage in a large kindred.  Medicine. 1977;  56 197-211
  PubMedGoogle Scholar
• 82 Searle J, Leggett B A, Crawford DHG, Powell L W. Iron storage diseases. In: MacSween RNM, Anthony PP, Scheuer PJ, Portmann BC, Burt AD, Ishak KG Pathology of the Liver. London, UK; Churchill Livingstone 2002: 257-272
  Google Scholar
• 83 Brissot P, Bourel M, Herry D et al.. Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods.  Gastroenterology. 1981;  80 557-565
  PubMedGoogle Scholar
• 84 Olynyk J, Hall P, Sallie R, Reed W, Shilkin K, Mackinnon M. Computerized measurement of iron in liver biopsies: a comparison with biochemical iron measurement.  Hepatology. 1990;  12 26-30
  CrossrefPubMedGoogle Scholar

Elizabeth M BruntM.D. 

Saint Louis University School of Medicine, 4th Floor

Saint Louis University Hospital, 3635 Vista Avenue

St. Louis, MO 63110

Email: bruntem@slu.edu